Genetic polymorphisms and their correlation with dyslipidemia in Chinese patients diagnosed with diabetes mellitus

Table 5 Subgroup analyses of association between genetic polymorphisms and dyslipidemia

Subgroup	APOE rs7412, OR (CI)	APOE rs429358, OR (CI)	LPL rs328, OR (CI)	CETP rs708272, OR (CI)
Age
< 60 yr	2.62 (0.91-7.54)	2.08 (1.25-3.46)	1.92 (1.06-3.48)	0.69 (0.44-1.08)
≥ 60 yr	3.11 (0.89-10.86)	2.24 (1.19-4.21)	2.27 (1.12-4.60)	0.51 (0.27-0.96)
Sex
Male	3.18 (1.03-9.81)	2.31 (1.33-4.03)	2.14 (1.14-4.03)	0.58 (0.34-0.99)
Female	2.41 (0.64-9.08)	1.96 (1.07-3.59)	1.94 (0.94-4.01)	0.68 (0.39-1.19)
BMI
< 25 kg/m²	2.95 (0.86-10.12)	2.06 (1.15-3.69)	2.18 (1.11-4.28)	0.60 (0.34-1.06)
≥ 25 kg/m²	2.68 (0.78-9.21	2.23 (1.27-3.92)	1.93 (1.00-3.73)	0.65 (0.38-1.11)
Diabetes type
Type 1	2.73 (0.61-12.21)	2.39 (1.09-5.24)	1.81 (0.72-4.55)	0.71 (0.32-1.57)
Type 2	2.88 (1.00-8.28)	2.04 (1.24-3.36)	2.18 (1.27-3.75)	0.59 (0.38-0.92)

OR: Odds ratio; 95%CI: 95% confidence interval; BMI: Body mass index.